22157.jpg
United Kingdom Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2023 Update
April 14, 2023 07:33 ET | Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "United Kingdom Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ...
22157.jpg
Transfection Reagents and Equipment Global Market Report 2023: Growing Demand for Synthetic Genes Fuels Sector
March 21, 2023 06:53 ET | Research and Markets
Dublin, March 21, 2023 (GLOBE NEWSWIRE) -- The "Transfection Reagents and Equipment Market by Product, by Method, by Application, by End User, and by Region - Global Forecast to 2022-2033" report...
Intellia.jpg
Intellia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NTLA-2002, an In Vivo CRISPR-Based Investigational Therapy for the Treatment of Hereditary Angioedema (HAE)
March 02, 2023 07:00 ET | Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies...
22157.jpg
Global Cell & Gene Therapy Business and Investment Opportunities Q1 2023 Update: Mergers and Acquisitions Continue to Dominate Growth Prospects
February 24, 2023 08:53 ET | Research and Markets
Dublin, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The "Global Cell & Gene Therapy Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial...
22157.jpg
Global Gene Editing Technology Market Report 2023 Featuring bluebird, Beam, Caribou Bio, Cellectis, Allogene, Intellia TX, Editas Medicine, Verve, AstraZeneca, Merck, & Thermo Fisher Scientific
February 21, 2023 11:43 ET | Research and Markets
Dublin, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The "Global Gene Editing Technology Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial...
Global Gene Therapy Market
Gene Therapy Global Market Report 2023: Increasing Prevalence of Cancer Fuels Demand
February 16, 2023 08:53 ET | Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type...
Global Gene Synthesis Market
Gene Synthesis Global Market Report 2023: Advent of Enzymatic DNA Synthesis Process Boosts Growth
February 16, 2023 08:48 ET | Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Gene Synthesis Market Size, Share & Trends Analysis Report By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By...
22157.jpg
Advances in Gene Editing Technologies in Healthcare, 2023 Research Report - Next-Generation Genome Editing Tools and Improved Delivery Are Bolstering Gene Editing Therapeutics and Diagnostics
February 10, 2023 10:53 ET | Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Advances in Gene Editing Technologies in Healthcare" report has been added to ResearchAndMarkets.com's offering. CRISPR, ZFNs, and TALENs are...
Global CRISPR Technology Market
CRISPR Technology Global Markets Report 2023: A $9.2 Billion Market by 2027, from $3.3 Billion in 2022
January 25, 2023 04:08 ET | Research and Markets
Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "CRISPR Technology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report provides detailed exposure to the...
Persistence Market Research
Synthetic Biology Market through Healthcare Sector to grow at 30% CAGR in Next 10 Years, Reveals Persistence Market Research 
January 17, 2023 10:30 ET | Persistence Market Research
New York, Jan. 17, 2023 (GLOBE NEWSWIRE) -- As per the latest report published by Persistence Market Research, a leading Market Research firm, the Synthetic Biology Market was valued at US$ 9.8...